The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biomarker Technology market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biomarker Technology market research.
Key companies engaged in the Biomarker Technology industry include Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding and Siemens Healthcare, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Biomarker Technology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biomarker Technology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Abbott Laboratories
- Quanterix
- Bio-Rad Laboratories
- Epigenomics
- Agilent Technologies
- Johnson & Johnson
- Qiagen
- Roche Holding
- Siemens Healthcare
- Myriad Genetics
Segment by Type
- Polymerase Chain Reaction(PCR)
- Next Generation Sequencing(NGS)
- Immunoassay
- Others
Segment by Application
- Cancer
- Infectious Diseases
- Auoimmune Disorders
- Cardiovascular Disorders
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
The Biomarker Technology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Technology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction(PCR)
1.2.3 Next Generation Sequencing(NGS)
1.2.4 Immunoassay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomarker Technology Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Auoimmune Disorders
1.3.5 Cardiovascular Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Technology Market Perspective (2018-2029)
2.2 Biomarker Technology Growth Trends by Region
2.2.1 Global Biomarker Technology Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biomarker Technology Historic Market Size by Region (2018-2023)
2.2.3 Biomarker Technology Forecasted Market Size by Region (2024-2029)
2.3 Biomarker Technology Market Dynamics
2.3.1 Biomarker Technology Industry Trends
2.3.2 Biomarker Technology Market Drivers
2.3.3 Biomarker Technology Market Challenges
2.3.4 Biomarker Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Technology Players by Revenue
3.1.1 Global Top Biomarker Technology Players by Revenue (2018-2023)
3.1.2 Global Biomarker Technology Revenue Market Share by Players (2018-2023)
3.2 Global Biomarker Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Technology Revenue
3.4 Global Biomarker Technology Market Concentration Ratio
3.4.1 Global Biomarker Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Technology Revenue in 2022
3.5 Biomarker Technology Key Players Head office and Area Served
3.6 Key Players Biomarker Technology Product Solution and Service
3.7 Date of Enter into Biomarker Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Technology Breakdown Data by Type
4.1 Global Biomarker Technology Historic Market Size by Type (2018-2023)
4.2 Global Biomarker Technology Forecasted Market Size by Type (2024-2029)
5 Biomarker Technology Breakdown Data by Application
5.1 Global Biomarker Technology Historic Market Size by Application (2018-2023)
5.2 Global Biomarker Technology Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biomarker Technology Market Size (2018-2029)
6.2 North America Biomarker Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biomarker Technology Market Size by Country (2018-2023)
6.4 North America Biomarker Technology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker Technology Market Size (2018-2029)
7.2 Europe Biomarker Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biomarker Technology Market Size by Country (2018-2023)
7.4 Europe Biomarker Technology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Technology Market Size (2018-2029)
8.2 Asia-Pacific Biomarker Technology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biomarker Technology Market Size by Region (2018-2023)
8.4 Asia-Pacific Biomarker Technology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker Technology Market Size (2018-2029)
9.2 Latin America Biomarker Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biomarker Technology Market Size by Country (2018-2023)
9.4 Latin America Biomarker Technology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Technology Market Size (2018-2029)
10.2 Middle East & Africa Biomarker Technology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biomarker Technology Market Size by Country (2018-2023)
10.4 Middle East & Africa Biomarker Technology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Biomarker Technology Introduction
11.1.4 Abbott Laboratories Revenue in Biomarker Technology Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Quanterix
11.2.1 Quanterix Company Detail
11.2.2 Quanterix Business Overview
11.2.3 Quanterix Biomarker Technology Introduction
11.2.4 Quanterix Revenue in Biomarker Technology Business (2018-2023)
11.2.5 Quanterix Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Biomarker Technology Introduction
11.3.4 Bio-Rad Laboratories Revenue in Biomarker Technology Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Detail
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Biomarker Technology Introduction
11.4.4 Epigenomics Revenue in Biomarker Technology Business (2018-2023)
11.4.5 Epigenomics Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Biomarker Technology Introduction
11.5.4 Agilent Technologies Revenue in Biomarker Technology Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biomarker Technology Introduction
11.6.4 Johnson & Johnson Revenue in Biomarker Technology Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Biomarker Technology Introduction
11.7.4 Qiagen Revenue in Biomarker Technology Business (2018-2023)
11.7.5 Qiagen Recent Development
11.8 Roche Holding
11.8.1 Roche Holding Company Detail
11.8.2 Roche Holding Business Overview
11.8.3 Roche Holding Biomarker Technology Introduction
11.8.4 Roche Holding Revenue in Biomarker Technology Business (2018-2023)
11.8.5 Roche Holding Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Detail
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Biomarker Technology Introduction
11.9.4 Siemens Healthcare Revenue in Biomarker Technology Business (2018-2023)
11.9.5 Siemens Healthcare Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Detail
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Biomarker Technology Introduction
11.10.4 Myriad Genetics Revenue in Biomarker Technology Business (2018-2023)
11.10.5 Myriad Genetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
